SEC Form 4 · accession 0001209191-16-134219
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peder Jensen
Director
Period of report
Jul 27, 2016
Accepted (ET)
Jul 28, 2016 · 12:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 27, 2016 | M | 12,195 | $8.49 | A | 12,195 | D | |
| Common Stock | Jul 27, 2016 | S | 12,195 | $49.50 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $8.49 | Jul 27, 2016 | M | 12,195 | D | — | Jul 13, 2021 | Common Stock | 12,195 | 0 | D |
Explanation of responses
- F1The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on April 5, 2016.
- F2This option is fully vested and immediately exercisable.